The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goodwin Charles D. Ii since 2020.
This trader's CIK number is 1726988.
At the time of last reporting, Goodwin Charles D. Ii was the Chief Executive Officer of Apyx Medical Corp. (stock ticker symbol APYX).
Also see all insider trading activities at Apyx Medical Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | APYX | 50,000 | $78,500 | 0 | $0 | 0 | $0 |
| 2022 | APYX | 11,750 | $69,912 | 0 | $0 | 0 | $0 |
| 2020 | APYX | 28,250 | $93,196 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-14 | APYX | Buy | 50,000 | 1.57 | 78,500 |
| 2022-08-29 | APYX | Buy | 11,750 | 5.95 | 69,912 |
| 2020-05-13 | APYX | Buy | 28,250 | 3.30 | 93,196 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goodwin Charles D. Ii (Chief Executive Officer of Apyx Medical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.